Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy

Res Microbiol. 1994 Mar-Apr;145(3):188-96. doi: 10.1016/0923-2508(94)90017-5.
No abstract available

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / blood
  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy
  • Acquired Immunodeficiency Syndrome / complications*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Clarithromycin / pharmacology
  • Clarithromycin / therapeutic use
  • Drug Resistance, Microbial
  • Humans
  • In Vitro Techniques
  • Mycobacterium avium Complex / drug effects*
  • Mycobacterium avium Complex / isolation & purification
  • Mycobacterium avium-intracellulare Infection / blood
  • Mycobacterium avium-intracellulare Infection / complications
  • Mycobacterium avium-intracellulare Infection / diagnosis*
  • Mycobacterium avium-intracellulare Infection / drug therapy
  • Rifabutin / pharmacology*
  • Rifabutin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Rifabutin
  • Clarithromycin